Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
Crossref DOI link: https://doi.org/10.3389/fphar.2018.01154
Published Online: 2018-10-15
Update policy: https://doi.org/10.3389/crossmark-policy
Raut, Sangram
Mooberry, Linda
Sabnis, Nirupama
Garud, Ashwini
Dossou, Akpedje Serena
Lacko, Andras
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (DP150091)
License valid from 2018-10-15